|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1725 I Street NW, Suite 900 |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20006 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 26422-24
|
||||||||
|
6. House ID# 302590000
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Tamara Chrisler |
Date | 7/22/2024 2:47:57 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Federal courts and judicial nominees;
Support for the continued confirmation of judges committed to civil and human rights;
Support for Supreme Court ethics reform and expansion;
Support for Congress to use oversight authority to investigate alleged ethics and financial scandals involving current Supreme Court justices;
H.R.3422 and S.1616, the Judiciary Act of 2023;
H.R.5566, the Supreme Court Tenure Establishment and Retirement Modernization (TERM) Act of 2023;
Issues related to the High Court Gift Ban Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
|
Stephanie |
Yost |
|
|
|
Emily |
McDowell |
|
|
|
Ryan |
Stitzlein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY25 appropriations for Departments of Labor, Health and Human Services, and Education, and related agencies, including the Hyde amendment, the Weldon amendment, increased funding for Title X, zeroing out abstinence-only education, increasing funding for the Teen Pregnancy Prevention Program, funding for entities that offer abortion care, and abortion-related executive orders;
FY25 appropriations for Department of State, Foreign Operations, and Related Programs, including the Helms amendment, the Hyde amendment, increased funding for international family planning and reproductive health programs, increased funding for UNFPA, ending the Kemp-Kasten amendment, and the Livingston amendment;
FY25 appropriations for Military Construction, Veterans Affairs, and Related Agencies, including veterans access to abortion services;
FY25 appropriations for Department Agriculture, Rural Development, Food and Drug Administration, including FDA approval of mifepristone;
FY25 appropriations for Department of Homeland Security, including coverage and provision of abortion services for individuals in ICE custody;
FY25 appropriations for Department of Defense, including access to abortion services and gender affirming care for servicemembers and their dependents;
FY25 appropriations for Financial Services and General Government, reproductive freedom attacks aimed at the District of Columbia, bans on abortion coverage for federal employees, denials of coverage for contraceptive care and supplies;
FY25 appropriations for Commerce, Justice, Science, and Related Agencies, including bans on abortion for people in federal prisons.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
|
Stephanie |
Yost |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Reproductive healthcare in FY25 federal spending bills;
A federal right to abortion;
A national ban on abortion;
Reproductive Rights and Roe v. Wade and Dobbs v. Jackson Womens Health Organization;
Assisted Reproductive Technology, including IVF;
S.4445 the Right to IVF Act, which would protect and expand access to assisted reproductive technologies, including IVF;
H.R.7056 and S.3612, the Access to Family Building Act;
H.Res.1043, purporting to support assisted reproductive technologies;
Federal issues related to state abortion bans and abortion access in the United States;
Child tax credit;
Administrative actions to protect and expand abortion access;
Access to reproductive health services, including contraception and abortion, for veterans and servicemembers and dependents;
H.R.8070 and S.4638 National Defense Authorization Act, access to reproductive health services, including contraception and abortion, for servicemembers and dependents;
Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services;
Denials of and nondiscrimination in healthcare, including S.4223 the Access to Birth Control Act;
Restrictions on funding for entities that provide abortion care, including medical training and defunding abortion providers;
Access to contraception and the right to contraception, including H.R.4121, S.1999, and S.4381 the Right to Contraception Act;
Regulations related to the federal sterilization consent form and process;
Access to and affordability of contraceptives, including those available OTC;
LGBTQI+ rights;
Title IX, including H.Res.165 and S.J.Res.96;
Discrimination against LGBTQI+ people;
Bans and restrictions on gender affirming care;
H.R.12 and S.701 the Women's Health Protection Act of 2023, regarding access to abortion care;
Access to evidence-based medication abortion care, including a resolution protecting personal, private medical decisions;
Issues related to the Comstock Act, including S.4619 and H.R.8796 the Stop Comstock Act;
Issues related Alliance for Hippocratic Medicine (AHM) v. FDA;
Issues related to Idaho v. United States and emergency abortion care;
Maternal and child health funding, including Title X and SET-NET;
Issues related to discrimination and mistreatment of pregnant people;
Paid Family and Medical Leave, including H.R.3481 and S.1714 the FAMILY Act;
H.Res.1273 and S.Res.703, a resolution designating a day in May 2024, as "Disability Reproductive Equity Day;"
Data and health records privacy as it relates to abortion care.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Justice - Dept of (DOJ), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
|
Stephanie |
Yost |
|
|
|
Ryan |
Stitzlein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R.7109, Equal Representation Act, which would exclude non-citizens from the congressional appointment count;
H.R.5008 and S.2646, Health Equity & Access under the Law (HEAL) for Immigrant Families Act, which would remove political interference and restore coverage so immigrants in the United States could participate in the health insurance programs for which they would be eligible but for their immigration status or length of stay.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amy |
Williams Navarro |
|
|
|
Mini |
Timmaraju |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
Voting Rights, including H.R.8281, SAVE Act, which would require proof of citizenship in order to register to vote;
S.4, John R. Lewis Voting Rights Advancement Act of 2024.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Emily |
McDowell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |